☆ 4.2 Article

Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease

PROTEIN EXPRESSION AND PURIFICATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

Jiahui Chen et al.

Summary: The Omicron variant of the SARS-CoV-2 virus has caused global panic due to its high infectivity and ability to escape vaccines. A comprehensive analysis using an artificial intelligence model and antibody structure analysis reveals that Omicron may be over 10 times more contagious than the original virus and has an 88% likelihood of vaccine escape. This study highlights the importance of developing mutation-proof vaccines and antibodies.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Crystal structure of SARS-CoV-2 papain-like protease

Xiaopan Gao et al.

Summary: This study provided structural frameworks for PLpro inhibitor design targeting SARS-CoV-2, showing that existing SARS-CoV PLpro inhibitors have some efficacy against SARS-CoV-2 and explored the inhibition mechanism of GRL0617.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Article Infectious Diseases

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020

Antonin Bal et al.

Summary: The study reported the strategy leading to the first detection of the variant of concern 202012/01 (VOC) in France, by screening for mutations such as Delta H69/Delta V70 associated with VOC and identifying co-occurring mutations like S:N501Y.

EUROSURVEILLANCE (2021)

添加到收藏夹

Review Chemistry, Medicinal

Therapeutic targets and potential agents for the treatment of COVID-19

Yinuo Wu et al.

Summary: The outbreak of COVID-19 has become a global crisis, with a need for effective treatments and drugs. The structure of SARS-CoV-2 is highly conserved, with enzymes identified as key targets for therapy. Repositioning existing drugs for treatment is a rapid approach that has shown efficacy in preclinical and clinical studies.

MEDICINAL RESEARCH REVIEWS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery

Ziyang Fu et al.

Summary: SARS-CoV-2 PLpro enzyme plays a critical role in virus maturation, host inflammation regulation, and antiviral immune responses, making it a promising drug target. The inhibitor GRL0617 has shown to effectively inhibit PLpro and has promising antiviral activity in vitro. This study provides insights into the mechanism of action of GRL0617 and highlights the potential of targeting the PLpro enzyme for antiviral drug discovery.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)

Salma Bessalah et al.

Summary: Nanobodies, as a revolutionary therapy for COVID-19, have the potential to guide drug discovery efforts. Their small size and strong antigen affinity make them effective in treating and preventing SARS-CoV-2 infection, controlling disease transmission and development.

3 BIOTECH (2021)

添加到收藏夹

Article Chemistry, Physical

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease

Kamonpan Sanachai et al.

Summary: Global public health faces a critical issue with the sudden increase in the COVID-19 outbreak. The study utilized MD simulations and binding free energy calculations to compare the binding behaviors of five inhibitors against SARS-CoV-2 PLpro, revealing that the inhibitors predominantly interact within the PLpro active site through vdW interactions, with specific hydrogen bond formations playing a crucial role in stabilizing the protein-ligand complexes. Among the inhibitors, VIR250 exhibited the highest binding efficiency with SARS-CoV-2 PLpro and was chosen for rational drug design.

JOURNAL OF PHYSICAL CHEMISTRY B (2021)

添加到收藏夹

Article Immunology

Immunogenicity Risk Profile of Nanobodies

Chloe Ackaert et al.

Summary: The study assessed the immunogenicity risk profile of two Nanobodies in phase II clinical trials and found that monomeric Nbs have a low immunogenicity risk profile, indicating their potential for future clinical applications.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Chemistry, Physical

Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies

Eleni Pitsillou et al.

Summary: The study used molecular docking to investigate the binding properties of dietary compounds and naphthalene-based inhibitors with the SARS-CoV-2 PLpro. The structures of the SARS-CoV-2 and SARS-CoV PLpro in complex with ISG15 and K48-linked diubiquitin were used to predict potential interference with the binding of these cellular modifiers.

CHEMICAL PHYSICS LETTERS (2021)

添加到收藏夹

Review Immunology

Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19

Shahab Mahmoudvand et al.

Summary: Coronaviruses are a family of respiratory viruses that can cause upper respiratory tract infections, with the recent discovery of SARS-CoV-2 posing a major threat to public health. These viruses have evolved strategies to evade host immunity, including the multifunctional enzyme PLpro, which regulates viral spread and immune responses. Inhibitors targeting the PLpro enzyme could be potential treatments for COVID-19.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies

Lee A. Armstrong et al.

Summary: Among the 16 non-structural proteins encoded by SARS CoV-2, Nsp3 is the largest and plays important roles in the viral life cycle. The papain-like protease domain (PLpro) encoded within Nsp3 cleaves viral polypeptide, as well as ubiquitin and ISG15 from host cell proteins. Screening clinical compounds, five were found to inhibit PLpro but showed no significant antiviral activity in cellular SARS-CoV-2 infection assays, highlighting the importance of alternative methods like engineered nanobodies to block PLpro activity.

PLOS ONE (2021)

添加到收藏夹

Review Oncology

The Therapeutic Potential of Nanobodies

Ivana Jovcevska et al.

BIODRUGS (2020)

添加到收藏夹

Review Virology

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Yu Chen et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Characterization and Noncovalent Inhibition of the Deubiquitinase and delSGylase Activity of SARS-CoV-2 Papain-Like Protease

Brendan T. Freitas et al.

ACS INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat

Shajeea Arshad Ali et al.

Journal of Infection and Public Health (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Donghyuk Shin et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design

Wioletta Rut et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Review Chemistry, Medicinal

Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations

Anastasiia I. Petushkova et al.

PHARMACEUTICALS (2020)

添加到收藏夹

Article Biochemical Research Methods

Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity

Marcin Poreba et al.

NATURE PROTOCOLS (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds

Yahira M. Baez-Santos et al.

ANTIVIRAL RESEARCH (2015)

添加到收藏夹

Article Biochemical Research Methods

A general protocol for the generation of Nanobodies for structural biology

Els Pardon et al.

NATURE PROTOCOLS (2014)

添加到收藏夹

Article Multidisciplinary Sciences

One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities

Lorenzo Subissi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

添加到收藏夹

Article Virology

Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and delSGylating activities

Anna M. Mielech et al.

VIRUS RESEARCH (2014)

添加到收藏夹

Review Cell Biology

The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection

Arianna Calistri et al.

CELLS (2014)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Virus-encoded proteinases and proteolytic processing in the Nidovirales

J Ziebuhr et al.

JOURNAL OF GENERAL VIROLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.